Aprea Therapeutics, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Aprea Therapeutics, Inc. (APRE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aprea Therapeutics, Inc. has filed 7 DEF 14A documents with the SEC since 2019. To view all SEC filings by Aprea Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001558370-25-005141 | Apr 22, 2025 | Jun 5, 2025 |
| DEF 14A | DEF 14A | 0001558370-24-005678 | Apr 25, 2024 | Jun 20, 2024 |
| DEF 14A | DEF 14A | 0001558370-23-011785 | Jul 11, 2023 | Aug 23, 2023 |
| DEF 14A | DEF 14A | 0001558370-22-015421 | Oct 26, 2022 | Nov 16, 2022 |
| DEF 14A | DEF 14A | 0001558370-22-009946 | Jun 10, 2022 | Jul 28, 2022 |
| DEF 14A | DEF 14A | 0001558370-21-005107 | Apr 28, 2021 | Jun 9, 2021 |
| DEF 14A | DEF 14A | 0001558370-20-004645 | Apr 29, 2020 | Jun 26, 2020 |